본문으로 건너뛰기
공식 EU 표시명용어집 항목 14905

LAURAMIDE DEA

이 기록은 EU 화장품 표시에 사용하는 공식 일반 원료 명칭을 확인해 줍니다. 그것만으로는 해당 물질이 허용되거나 제한이 없거나 안전하다는 것이 확인되지 않습니다.

글로벌 근거 요약

확인된 정체는 색인된 시장 데이터세트 13개 중 0개에서 일치하는 규제 근거가 있습니다: 국가 기록 0건과 EU 부속서 기록 0건. 모든 결과와 근거 부족 사항은 아래에 나열되어 있습니다.

근거가 있는 시장 0곳
확인한 시장
13
근거가 있는 시장
0
근거 부족
13
확인된 식별자
2

확인된 물질 정체

CAS:120-40-1
EC:204-393-1
원료 색인 기록:
LAURAMIDE DEA
화장품 기능: ANTISTATIC, SURFACTANT - CLEANSING, SURFACTANT - FOAM BOOSTING, VISCOSITY CONTROLLING

N,N-bis(2-Hydroxyethyl)dodecanamide

목록 제한 사항 주석: III/60

일치 또는 보고된 명칭 1개
LAURAMIDE DEA

시장별 규제 근거

여기에서 추적하는 시장 13곳 중 어느 곳에도 LAURAMIDE DEA이라는 명칭으로 가져온 규칙이 없습니다.

이는 이 목록에 관한 설명이지 법에 관한 설명이 아닙니다. 가져온 규칙이 없다는 것이 해당 물질이 허용된다는 근거는 아닙니다. 규칙은 다른 명칭으로, 이 용어집 항목에 없는 CAS 또는 EC 번호로, 또는 아직 가져오지 않은 데이터세트에 존재할 수 있습니다.

화학적 정체 및 특성

CAS 120-40-1의 PubChem 2D 화학 구조
CAS 120-40-1PubChem CID 8430

Lauric acid diethanolamide

Lauric acid diethanolamine condensate (1/1) is an off-white waxy solid. (NTP, 1992) — CAMEO Chemicals

IUPAC 명칭
N,N-bis(2-hydroxyethyl)dodecanamide
분자식
C16H33NO3
분자량
287.44 g/mol
정확한 질량
287.24604391 Da
XLogP3
3.5
위상 극성 표면적
60.8 Ų
수소 결합 공여체
2
수소 결합 수용체
3
공유결합 단위
1
정의된 입체중심
0

다른 이름

Lauric diethanolamideLauramide DEALauryl diethanolamideAlkamide LEStandamidd ldComperlan LDCondensate PLMackamide LL
보고된 명칭 16개 더 보기
DiethanollauramideHetamide MLMackamide LLMEmpilan LDEEthylan MLDLauroyldiethanolamineClindrol 100LRolamid cdLankrostat JPIncromide LRStandamid LDLauramido DEAN,N-Bis(2-hydroxyethyl)lauramideRichamide STDAminon L 02Lalmin D
외부 데이터베이스 식별자

추가 과학 데이터베이스의 근거

NIH PubChem PUG-View
식별자 정확히 일치8430

Attributed physical-property, hazard, environmental and use annotations.

  • Boiling Point: 462 to 471 °F at 760 mmHg (NTP, 1992) 출처: CAMEO Chemicals
  • Substance: Lauric Acid Diethanolamine Condensate 출처: NTP Technical Reports
  • NTP Technical Report: TR-480: Toxicology and Carcinogenesis Studies of Lauric Acid Diethanolamine Condensate (CASRN 120-40-1) in F344/N Rats and B6C3F1 Mice (Dermal Studies) (1999 ) 출처: NTP Technical Reports
  • Peer Review Date: 12/10/97 출처: NTP Technical Reports
  • Conclusion for Male Rat: No Evidence 출처: NTP Technical Reports
  • Conclusion for Female Rat: No Evidence 출처: NTP Technical Reports
  • Conclusion for Male Mice: No Evidence 출처: NTP Technical Reports
  • Conclusion for Female Mice: Some Evidence 출처: NTP Technical Reports
  • Summary: Under the conditions of these 2-year dermal studies, there was no evidence of carcinogenic activity of lauric acid diethanolamine condensate in male or female F344/N rats administered 50 or 100 mg/kg or in male B6C3F1 mice administered 100 or 200 mg/kg. There was some evidence of carcinogenic activity in female B6C3F1 mice based on increased incidences of hepatocellular neoplasms. These increases were associated with free diethanolamine, which was present as a contaminant of lauric acid diethanolamine condensate.; Dermal administration of lauric acid diethanolamine condensate to rats and mice for 2 years resulted in increased incidences of epidermal and sebaceous gland hyperplasia, hyperkeratosis, chronic inflammation, and parakeratosis at the site of application.; Lauric acid diethanolamine condensate administration also resulted in increased incidences of thyroid gland follicular cell hyperplasia in dosed male mice. 출처: NTP Technical Reports
  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) shou 출처: CAMEO Chemicals
  • Signal: Danger 출처: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H315 (45.4%): Causes skin irritation [Warning Skin corrosion/irritation]; H318 (93.9%): Causes serious eye damage [Danger Serious eye damage/eye irritation]; H411 (27.1%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] 출처: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P264, P264+P265, P273, P280, P302+P352, P305+P354+P338, P317, P321, P332+P317, P362+P364, P391, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 809 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
  • Cosmetic Ingredient Review Conclusion: The CIR Expert Panel concluded that the following 33 diethanolamides are safe in the present practices of use and concentration described in this safety assessment when formulated to be non-irritating and when the levels of free diethanolamine in the diethanolamides do not exceed the present practices of use and concentration of diethanolamine itself. The Expert Panel cautions that ingredients should not be used in cosmetic products in which N-nitroso compounds can be formed...Lauramide DEA... 출처: Cosmetic Ingredient Review (CIR)
  • Cosmetic Ingredient Review Finding(s): Safe for use in cosmetics, with qualifications 출처: Cosmetic Ingredient Review (CIR)
  • Environmental Bioconcentration: Based upon an estimated water solubility of 226 mg/l(1), the BCF of N,N-di(2-hydroxyethyl)lauramide can be estimated to be approximately 29 from a regression-derived equation(1). Based on this BCF value, bioconcentration is not expected to be an important fate process(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: When dissolved in aqueous solutions, N,N-di(2-hydroxyethyl)lauramide will have soil mobility ranging from medium to high(3) based on estimated Koc values ranging from 52 to 221(1,2). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: N,N-Di(2-hydroxyethyl)lauramide is essentially nonvolatile from water based upon an estimated Henry's Law constant of 2.16X10-12 atm cu m/mol(1,2,SRC). In natural river water, 98% of N,N-di(2-hydroxyethyl)lauramide was biodegraded in 6 days (20 mg/l)(3). Aquatic bioconcentration and adsorption to sediment are not expected to be important fate processes(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: Based on an estimated vapor pressure of approximately 6.7X10-9 mm Hg at 25 °C(1), N,N-di(2- hydroxyethyl)lauramide will exist primarily in the particulate phase in the ambient atmosphere(2). In the vapor phase, it will degrade in the ambient atmosphere by reaction with photochemically produced hydroxyl radicals with an estimated half-life of 8 hrs(3). Physical removal of particulate N,N-di(2- hydroxyethyl)lauramide from air is likely to occur through wet and dry deposition(SRC). 출처: Hazardous Substances Data Bank (HSDB)

매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기

과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.

추가 출처 적용 범위 및 일치 상태
출처결과확인됨
NIH PubChem PUG-View정확히 일치2026-08-31

기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

추가 공신력 있는 물질 조사

각 링크는 해당 출처에서 이 정체를 검색합니다. 링크는 조사 경로일 뿐이며, 그 출처에 정확히 일치하는 기록이 있다는 주장이 아닙니다. 각 출처의 성격과 법적 비중

이 기록 활용하기

처방에서 선별독립 비교 열기

공식 출처 및 범위

집행위원회 시행결정 (EU) 2025/1175(데이터세트 버전 EU 2025/1175)에서 가져왔습니다. 이 용어집은 제19조 제1항 (g)호에서 요구하는 성분 목록에 사용할 일반 원료 명칭을 제공하며, 승인 또는 안전성 목록이 아닙니다.

공식 결정 열기